Concert Pharmaceuticals, Inc. Total Assets
Concert Pharmaceuticals, Inc. had Total Assets of $171.13 million as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2022-11-07
- 2022-09-30: Assets $171.13M.
- 2022-06-30: Assets $176.39M.
- 2022-03-31: Assets $129.41M.
- 2021-12-31: Assets $165.32M.
| Period end | Assets |
|---|---|
| 2022-09-30 | $171.13M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $176.39M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $129.41M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $165.32M 10-Q · filed 2022-11-07 |
| 2021-09-30 | $128.21M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $148.71M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $139.99M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $159.26M 10-K · filed 2022-03-03 |
| 2020-09-30 | $153.37M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $172.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $187.28M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $137.47M 10-K · filed 2021-02-25 |
| 2019-09-30 | $151.96M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $166.60M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $183.39M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $192.55M 10-K · filed 2020-02-27 |
| 2018-09-30 | $208.56M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $220.51M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $227.65M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $211.74M 10-K · filed 2019-02-28 |
| 2017-09-30 | $212.23M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $108.62M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $89.03M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $100.39M 10-K · filed 2018-03-01 |
| 2016-09-30 | $112.36M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $122.63M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $133.29M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $146.93M 10-K · filed 2017-03-06 |
| 2015-09-30 | $146.25M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $156.20M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $118.36M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $84.45M 10-K · filed 2016-03-01 |
| 2014-09-30 | $95.74M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $103.71M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $113.63M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $39.77M 10-K · filed 2015-03-02 |